Related Experiment Video
Updated: Jun 24, 2025

12:47
Inducing Plasticity of Astrocytic Receptors by Manipulation of Neuronal Firing Rates
Published on: March 20, 2014
14.2K
Norepinephrine changes behavioral state via astroglial purinergic signaling
Alex B Chen1,2,3, Marc Duque2,3, Vickie M Wang2,3
1Janelia Research Campus, Howard Hughes Medical Institute; Ashburn, VA 20147, USA.
Biorxiv : the Preprint Server for Biology
|June 3, 2024
Summary
Norepinephrine
Area of Science:
- Neuroscience
- Cellular Biology
- Neuroimmunology
Background:
- Neurons and glia utilize neuromodulatory substances for communication, yet the computational basis remains elusive.
- Norepinephrine (NE) is a neuromodulator that influences behavior and neural activity during transitions.
- The precise mechanisms underlying NE-mediated delayed inhibition are not fully understood.
Purpose of the Study:
- To elucidate the role of astroglial purinergic signaling in mediating the inhibitory effects of norepinephrine.
- To identify the specific signaling molecules and receptors involved in this pathway.
- To understand the computational and behavioral significance of this conserved signaling axis.
Main Methods:
- Neuromodulator imaging in larval zebrafish to track signaling dynamics.
- Behavioral pharmacology to assess the impact of specific compounds on behavior.
- Perturbation studies in both neurons and astroglia to dissect pathway components.
- Analysis of norepinephrine's effect on astroglial ATP release and subsequent adenosine formation.
Main Results:
- Norepinephrine triggers the release of adenosine triphosphate (ATP) from astroglia.
- Extracellular enzymes convert released ATP into adenosine.
- Adenosine activates hindbrain neuronal adenosine receptors, leading to behavioral suppression.
- This pathway mediates the delayed inhibitory effects of norepinephrine during behavioral transitions.
Conclusions:
- Astroglial purinergic signaling is the key mechanism for norepinephrine-induced behavioral inhibition.
- The norepinephrine-astroglia-adenosine pathway is evolutionarily conserved, playing a role in brain state transitions.
- This study reveals a novel computational role for glia in neuromodulatory networks.
Related Concept Videos
Adrenergic Neurons: Neurotransmission
3.7K
Postganglionic sympathetic fibers (except those supplying the sweat glands) releasing noradrenaline or norepinephrine are called noradrenergic or adrenergic neurons. Noradrenaline, dopamine, adrenaline, or epinephrine are collectively called "catecholamines" as they contain a catechol moiety and an amine side chain. The five stages of neurotransmitter release involve their synthesis, storage, release, reuptake and metabolism.
Synthesis: Catecholamine synthesis requires tyrosine, which...
Synthesis: Catecholamine synthesis requires tyrosine, which...
3.7K
Sympathetic Signaling
945
Sympathetic signaling, a vital part of the autonomic nervous system, plays a crucial role in mobilizing the body's resources in response to stress or emergencies. It involves the transmission of nerve impulses from sympathetic preganglionic fibers to postganglionic fibers. This results in the release of specific neurotransmitters and activation of adrenergic receptors.
Sympathetic preganglionic fibers release the neurotransmitter acetylcholine (ACh) onto the ganglionic neurons in the...
Sympathetic preganglionic fibers release the neurotransmitter acetylcholine (ACh) onto the ganglionic neurons in the...
945
Drugs Affecting Neurotransmitter Release or Uptake
1.0K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.0K
Adrenergic Receptors: β Subtype
1.6K
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
1.6K
GPCRs Regulate Adenylyl Cylase Activity
5.5K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.5K
Adrenergic Receptors (Adrenoceptors): Classification
2.5K
Adrenergic receptors, or adrenoceptors, respond to the autonomic neurotransmitter noradrenaline and other endogenous catecholamine agonists. They are classified into two main families, α and β, based on their pharmacological response and are further subdivided depending on their location, elicited response, and affinity to specific agonists or antagonists.
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors,...
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors,...
2.5K

